Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | Arthritis Res Ther

Figure 2

From: Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin

Figure 2

Amino acid sequence of vimentin with Sa microsequences and sequence of human vimentin (Swiss-Prot database number P08670). Two distinct peptides that were obtained by microsequencing are indicated in grey. Peptide 72–86 was obtained twice, VD84–85 was ambiguous in one of the peptides, and R78 could not be sequenced in both peptides. All arginines are given in capital and bold, because they can potentially be modified to citrulline by peptidylarginine deiminase.

Back to article page